Table S2: Comparison of minor allele frequencies (MAFs) at 191 SNPs of 42 genes between 190 infertile patients and 190 fertile males (1st round of initial screening)
OKADA, Hiroyuki, et al. Genome-wide expression of azoospermia testes demonstrates a specific profile and implicates ART3 in genetic susceptibility. PLoS genetics, 2008, 4. Jg., Nr. 2, S. e26.
Publication: https://doi.org/10.1371/journal.pgen.0040026
Description
Disclaimer
The publication Genome-Wide Expression of Azoospermia Testes Demonstrates a Specific Profile and Implicates ART3 in Genetic Susceptibility by Hiroyuki Okada and Atsushi Tajima and Kazuyoshi Shichiri and Atsushi Tanaka and Kenichi Tanaka and Ituro Inoue is published under an open access no derivatives license: : https://creativecommons.org/. Open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Curation by the MFGA team
Pie chart of selected column
Table
ARTIFACTID | CHR | GENE | Localization | Variation | MafCase | MafControl | SequencePositiona |
---|---|---|---|---|---|---|---|
rs2146162 | (6q25.3) | ACAT2 | 5-upstream | G/A | 39.1% | 35.8% | -1984 |
rs9364535 | (6q25.3) | ACAT2 | intron4 | A/T | 39.0% | 35.6% | 7532 |
rs2273828 | (6q25.3) | ACAT2 | 3-downstream | A/G | 19.5% | 19.7% | 23963 |
rs9995300 | (4q21.1) | ART3 | 5-upstream | A/G | 41.3% | 36.7% | -2520 |
rs17001357 | (4q21.1) | ART3 | intron3 | C/T | 40.5% | 42.8% | 12048 |
rs11097230 | (4q21.1) | ART3 | intron3 | A/G | 34.0% | 36.8% | 19801 |
rs6836703 | (4q21.1) | ART3 | intron11 | G/A | 42.9% | 36.6% | 34283 |
rs1128864 | (4q21.1) | ART3 | exon12-non-synonymous | T/C | 39.5% | 36.1% | 37726 |
rs6840007 | (4q21.1) | ART3 | 3-downstream | A/T | 34.7% | 31.9% | 43329 |
rs13415981 | (2q14) | BUB1 | 5-upstream | A/G | 6.7% | 7.3% | -3947 |
rs11903773 | (2q14) | BUB1 | intron6 | C/T | 7.2% | 6.7% | 9926 |
rs7609252 | (2q14) | BUB1 | intron9 | A/G | 6.8% | 7.6% | 16200 |
rs7581640 | (2q14) | BUB1 | intron19 | T/C | 6.0% | 5.4% | 34693 |
rs13398617 | (2q14) | BUB1 | intron24 | T/C | 6.9% | 7.4% | 37155 |
rs13419537 | (2q14) | BUB1 | 3-downstream | C/T | 6.8% | 8.0% | 43371 |
rs7819740 | (8p21.2) | CDCA2 | 5-upstream | G/T | 33.9% | 35.2% | -4478 |
rs3812422 | (8p21.2) | CDCA2 | 5’-UTR | A/C | 31.8% | 32.5% | 149 |
rs4872315 | (8p21.2) | CDCA2 | intron7 | T/G | 33.4% | 34.4% | 16088 |
rs11135869 | (8p21.2) | CDCA2 | intron7 | G/A | 33.4% | 34.3% | 18842 |
rs2271104 | (8p21.2) | CDCA2 | intron11 | C/T | 33.4% | 33.9% | 27124 |
rs7826705 | (8p21.2) | CDCA2 | intron13 | T/A | 30.1% | 34.1% | 36321 |
rs4872318 | (8p21.2) | CDCA2 | exon15-non-synonymous | G/A | 16.8% | 16.2% | 47819 |
rs7943007 | (11q12.1) | CDCA5 | 5-upstream | C/G | 13.0% | 13.4% | -5574 |
rs489489 | (11q12.1) | CDCA5 | 3’-UTR | C/A | 13.2% | 13.6% | 6086 |
rs565211 | (16q24.3) | CDT1 | 5-upstream | C/T | 25.1% | 29.2% | -1935 |
rs475667 | (16q24.3) | CDT1 | exon2-synonymous | T/C | 19.6% | 19.5% | 780 |
rs480727 | (16q24.3) | CDT1 | exon3-non-synonymous | A/G | 24.2% | 26.8% | 2042 |
rs8191478 | (16q24.3) | CDT1 | 3-downstream | C/T | 43.3% | 41.4% | 7242 |
rs9633172 | (Xq26.3) | CT45-2 | 3-downstream | A/G | 11.6% | 8.2% | 11971 |
rs13064112 | (3p24.3) | DAZL | 5-upstream | A/G | 29.7% | 29.5% | -5891 |
rs4234538 | (3p24.3) | DAZL | 5-upstream | C/G | 23.4% | 28.2% | -542 |
rs11710967 | (3p24.3) | DAZL | exon2-synonymous | G/A | 6.8% | 6.5% | 6931 |
rs3773826 | (3p24.3) | DAZL | intron9 | G/A | 10.5% | 11.1% | 12693 |
rs10510452 | (3p24.3) | DAZL | 3-downstream | A/G | 15.6% | 15.8% | 21958 |
rs16884506 | (5q11.2) | DDX4 | 5-upstream | A/G | 31.2% | 27.7% | -6616 |
rs3761772 | (5q11.2) | DDX4 | intron1 | A/G | 31.8% | 30.0% | 235 |
rs17699426 | (5q11.2) | DDX4 | intron1 | A/G | 12.4% | 13.5% | 4634 |
rs12653775 | (5q11.2) | DDX4 | intron2 | C/T | 43.8% | 43.3% | 12368 |
rs4865627 | (5q11.2) | DDX4 | intron2 | C/G | 48.3% | 43.5% | 17485 |
rs3761776 | (5q11.2) | DDX4 | intron3 | C/A | 45.3% | 42.4% | 25139 |
rs12652234 | (5q11.2) | DDX4 | intron5 | C/G | 43.7% | 39.1% | 29062 |
rs7378817 | (5q11.2) | DDX4 | intron6 | T/C | 28.9% | 27.3% | 36492 |
rs3789195 | (5q11.2) | DDX4 | intron16 | T/C | 47.1% | 43.7% | 60193 |